Healthspan Action Coalition and Leading Italian Organizations Announce Global Collaboration

TBA at the Translational Longevity Summit in Boston: International Partnership unites U.S. and Italian leadership in healthy longevity science — from prevention to public engagement — to extend the worldwide health span

Key Takeaways

  • HSAC is partnering with leading Italian health, science, academic and civic organizations to advance healthy aging and longevity through research collaboration, prevention, education and policy engagement. The Italy-U.S. initiative will be formally announced at the Translational Longevity Summit in Boston, October 7–11.
  • HSAC and a coalition of prominent Italian organizations are launching a cross-border initiative focused on extending healthy human life. The collaboration will connect scientists, clinicians, universities, foundations, policymakers and advocates to accelerate preventive health, regenerative medicine and longevity science.
  • A new Italy-U.S. healthspan alliance is bringing together HSAC and leading Italian organizations to turn advances in longevity science into practical action. The initiative emphasizes earlier prevention, international scientific cooperation, public education and policies designed to help people remain healthier as they age.

The Healthspan Action Coalition (HSAC) today announced a strategic international collaboration with a coalition of prominent Italian organizations, including Fondazione Bicocca, Italian Sources for Healthspan and Saturnia Healthy Longevity, Palazzo Fiuggi, Columbus Clinic Center, Tennis & Friends, Women Economic Forum Italy, BrainCircle Italy, AEON Foundation, and The Cure Alliance (Italy Healthspan Initiative), to advance scientific innovation, public understanding, policy engagement, and practical action aimed at extending healthy human life.

Through the new collaboration, HSAC and its Italian partners are creating a platform for cooperation across longevity and aging science, regenerative medicine, preventive health, education, convening, and public-policy dialogue. The alliance will connect investigators, clinicians, entrepreneurs, patient advocates, universities, foundations, women’s leadership networks, and public institutions in both countries and internationally.

Spearheaded by Camillo Ricordi, M.D., HSAC Chief Scientific Officer, the initiative connects scientific, civic, philanthropic, and institutional leaders around a shared global healthspan agenda. The collaboration reflects HSAC’s mission to deliver extended healthspan across the world.

“The science is moving rapidly toward a new paradigm: intervening earlier to identify invisible risk factors years before they progress toward disease, preserving function and preventing chronic illness by fully integrating predictive and preventive strategies. This will reduce the overburdening of a reactive health system already straining in the face of worldwide aging populations,” said Ricordi.

“This collaboration couldn’t come at a more urgent time,” said Bernard Siegel, JD, co-founder and executive director of HSAC. “It dovetails with our goal of improving the healthspan for all people, regardless of race, gender, geography or socioeconomic level. Nations across the globe need unprecedented measures to circumvent the potential social, humanitarian and economic problems of the coming aging tsunami by ensuring that health and vitality are achievable well into the older years.”

Marco Peronaci, the Italian Ambassador to the United States, said, “I am particularly pleased to see Italian scientific and civil-society organizations joining forces with their American partners in an initiative that places prevention, scientific evidence and international cooperation at its core.”

The initiative will be formally announced during the opening program of the Translational Longevity Summit in Boston, where Giovanna Iannantuoni, President of Fondazione Bicocca and a leader in academic, cultural, and international engagement, will deliver opening remarks recognizing the importance of an expanded Italy-United States partnership for healthspan. The upcoming Summit will take place October 7 - 11 at Harvard University’s new Enterprise Research Center in Boston, MA.

“Our overarching mission requires collaboration across disciplines, institutions, and national borders. This Italy-HSAC initiative is designed to bring scientific excellence together with public leadership, education, and implementation, so that advances in regenerative medicine, prevention, and longevity science can benefit people around the world,” said Iannantuoni.

A cross-border platform for healthspan

The partners will explore joint activities that may include:

  • International forums, conference programming, and expert exchanges on healthy aging, longevity science, regenerative medicine, and prevention.

  • Public education initiatives that communicate evidence-based approaches to healthspan in accessible language.

  • Connections among researchers, clinicians, academic institutions, foundations, policymakers, patient advocates, and responsible innovators.

  • Dialogue on policy, investment, and health-system strategies that support disease prevention, functional independence, and equitable access to emerging healthspan advances.

  • Opportunities to elevate women’s leadership, intergenerational engagement, and cross-sector participation in shaping the future of health and longevity.

“This is a historic moment in the field of healthspan,” said Siegel. “We’re deeply honored to be working with some of Italy’s most prominent health and longevity organizations on our shared goals for the good of people everywhere.”

An official part of Boston Longevity Week, the Translational Longevity Summit is produced under the Boston BioLife umbrella in collaboration with the Healthspan Action Coalition, World Stem Cell Summit and Regenerative Medicine Foundation. 


About The Healthspan Action Coalition

The Healthspan Action Coalition is a nonprofit, cross-sector coalition advancing “Healthspan for All”: More years of health, independence and dignity for all people through science, policy, patient advocacy and collaboration. Visit healtspanaction.org and translationallongevity.com to learn more about the Translational Longevity Summit 2026.

Resources

Media Gallery

“
“This collaboration couldn’t come at a more urgent time. It dovetails with our goal of improving the healthspan for all people, regardless of race, gender, geography or socioeconomic level. Nations across the globe need unprecedented measures to circumvent the potential social, humanitarian and e...
Bernard Siegel, JD — co-founder and executive director of HSAC
“
“Our overarching mission requires collaboration across disciplines, institutions, and national borders. This Italy-HSAC initiative is designed to bring scientific excellence together with public leadership, education, and implementation, so that advances in regenerative medicine, prevention, and ...
Giovanna Iannantuoni — President of Fondazione Bicocca

Scientific inquiries

Camillo Ricordi, MD Chief Scientific Officer
305-582-7151

Media Contact

Joseph Dawson, Director of Communications,
561-906-4755

Media Contact

Bernard Siegel, JD Executive Director, HSAC
305-801-4928

The main goal of the HSAC collaboration with Italian organizations is to advance scientific innovation, public understanding, policy engagement, and practical actions aimed at extending healthy human life.

This collaboration will create a platform for cooperation across various fields including longevity science, regenerative medicine, and preventive health, allowing for joint activities such as international forums, public education initiatives, and policy dialogues.

The collaboration is deemed urgent as it addresses the critical need for new measures to manage the challenges posed by an aging global population, aiming to ensure health and vitality for individuals of all demographics into their later years.

The HSAC and its partners will focus on areas including health aging, preventive health strategies, education on healthspan, and dialogue on policy and investment to support equitable access to health advancements.

Key figures leading this initiative include Camillo Ricordi, M.D., HSAC Chief Scientific Officer, and Giovanna Iannantuoni, President of Fondazione Bicocca, who will be instrumental in introducing the collaboration during the Translational Longevity Summit.